Vidyasagar Koduri, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thalidomide | 2 | 2021 | 885 | 0.560 |
Why?
|
| Oncogene Proteins | 1 | 2021 | 719 | 0.550 |
Why?
|
| Ikaros Transcription Factor | 2 | 2021 | 232 | 0.310 |
Why?
|
| Peptides | 2 | 2019 | 4338 | 0.300 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2007 | 118 | 0.280 |
Why?
|
| Protein Folding | 2 | 2007 | 867 | 0.250 |
Why?
|
| Hexosyltransferases | 1 | 2024 | 58 | 0.230 |
Why?
|
| Mesoderm | 1 | 2007 | 673 | 0.230 |
Why?
|
| Proteins | 1 | 2019 | 6033 | 0.230 |
Why?
|
| Molecular Chaperones | 1 | 2007 | 755 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 577 | 0.180 |
Why?
|
| Benzylamines | 1 | 2021 | 247 | 0.170 |
Why?
|
| Receptors, LDL | 1 | 2001 | 490 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2019 | 169 | 0.150 |
Why?
|
| Glutathione | 1 | 2019 | 583 | 0.130 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 2205 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2024 | 2485 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1135 | 0.120 |
Why?
|
| Quinazolines | 1 | 2021 | 1371 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2019 | 1007 | 0.110 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 1023 | 0.100 |
Why?
|
| Antioxidants | 1 | 2019 | 1669 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2898 | 0.090 |
Why?
|
| Pancreatic Diseases | 1 | 1992 | 343 | 0.090 |
Why?
|
| Catalytic Domain | 2 | 2024 | 705 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2019 | 2859 | 0.080 |
Why?
|
| Cell Survival | 1 | 2019 | 5785 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 1992 | 1626 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2024 | 7850 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 931 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2007 | 719 | 0.050 |
Why?
|
| Protein Binding | 2 | 2007 | 9339 | 0.050 |
Why?
|
| Mice | 4 | 2024 | 81406 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2021 | 12113 | 0.050 |
Why?
|
| Glycosylation | 1 | 2024 | 1097 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2024 | 23405 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 650 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 507 | 0.040 |
Why?
|
| Buthionine Sulfoximine | 1 | 2019 | 17 | 0.040 |
Why?
|
| Disulfides | 1 | 2001 | 465 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 23 | 0.040 |
Why?
|
| Tuberculosis | 1 | 1992 | 2012 | 0.040 |
Why?
|
| Ubiquitinated Proteins | 1 | 2019 | 32 | 0.040 |
Why?
|
| Thiocyanates | 1 | 2019 | 70 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 1974 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 1229 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1994 | 4024 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1693 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3429 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2001 | 1539 | 0.040 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 203 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 271 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 2749 | 0.040 |
Why?
|
| Animals | 4 | 2024 | 168245 | 0.040 |
Why?
|
| Cysteine | 1 | 2001 | 892 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 1994 | 5358 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2019 | 570 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2024 | 4273 | 0.030 |
Why?
|
| Ligands | 1 | 2001 | 3269 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2001 | 3969 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3734 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1887 | 0.030 |
Why?
|
| Organoids | 1 | 2019 | 741 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 3603 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2001 | 5424 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 3760 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1994 | 505 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3592 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 13442 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10758 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2001 | 4232 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 17617 | 0.020 |
Why?
|
| Humans | 6 | 2024 | 760239 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3109 | 0.020 |
Why?
|
| Inflammation | 1 | 2024 | 10744 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22127 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 39928 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1994 | 20550 | 0.010 |
Why?
|
| Female | 2 | 2019 | 391766 | 0.000 |
Why?
|
| Aged | 1 | 1994 | 168773 | 0.000 |
Why?
|
| Adult | 1 | 1992 | 220718 | 0.000 |
Why?
|
| Male | 1 | 1992 | 359943 | 0.000 |
Why?
|